Top News Stories
Cost-Containment
Eliquis patent expiry may cut employers' blood thinner spending
By Allison BellFor employers, the expiration of the patent on the brand-name blood thinner could lead to lower costs and improved patient care.
For employers, the expiration of the patent on the brand-name blood thinner could lead to lower costs and improved patient care.